Valuation : Lee's Pharmaceutical Holdings Limited

Market Cap 724M 92.37M 79.48M 74.78M 68.31M 128M 8.72B 128M 884M 343M 4.47B 347M 339M 14.41B P/E 2024
8.98x
P/E 2025 9.74x
Enterprise Value 685M 87.31M 75.13M 70.69M 64.57M 121M 8.24B 121M 835M 324M 4.23B 328M 321M 13.63B EV / Sales 2024
0.6x
EV / Sales 2025 0.6x
Free-Float
50.73%
Yield 2024
3.17%
Yield 2025 2.96%
1 day-2.38%
1 week-8.21%
Current month-4.28%
1 month+13.89%
3 months+14.95%
6 months-6.82%
Current year-19.08%
1 week 1.22
Extreme 1.215
1.34
1 month 1.05
Extreme 1.05
1.42
Current year 0.99
Extreme 0.99
1.69
1 year 0.99
Extreme 0.99
2.7
3 years 0.99
Extreme 0.99
2.7
5 years 0.99
Extreme 0.99
4.17
10 years 0.99
Extreme 0.99
14.7
Manager TitleAgeSince
Chief Executive Officer 73 01/04/1997
Director of Finance/CFO 53 07/10/2014
Chief Tech/Sci/R&D Officer 44 -
Director TitleAgeSince
Chairman 70 05/04/2010
Director/Board Member 73 01/12/2001
Director/Board Member 63 01/09/2003
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 A Other

Chief Executive Officer

41,500 0.0070%
5/28/26 A Other

Chief Executive Officer

200,000 0.0340%
10/15/25 A Other

Chief Executive Officer

588,000 0.0999%
Change 5-day change 1-year change 3-year change Capi.($)
-2.38%-8.21%-41.98%-0.81% 92.37M
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -1.13%+0.16%+21.27%+45.94% 367.85B
Weighted average by Cap. -1.10%+0.55%+36.62%+66.22%

Financials

2024 2025
Net sales 1.4B 179M 154M 145M 132M 247M 16.86B 248M 1.71B 663M 8.65B 670M 656M 27.86B 1.44B 183M 158M 148M 135M 253M 17.29B 254M 1.75B 680M 8.87B 688M 673M 28.58B
Net income 93.1M 11.87M 10.22M 9.61M 8.78M 16.43M 1.12B 16.47M 114M 44.08M 575M 44.58M 43.61M 1.85B 91.94M 11.72M 10.09M 9.49M 8.67M 16.22M 1.11B 16.27M 112M 43.53M 568M 44.03M 43.07M 1.83B
Net Debt 10.45M 1.33M 1.15M 1.08M 986K 1.84M 126M 1.85M 12.75M 4.95M 64.58M 5.01M 4.9M 208M -39.63M -5.05M -4.35M -4.09M -3.74M -6.99M -477M -7.01M -48.35M -18.76M -245M -18.98M -18.56M -789M
Logo Lee's Pharmaceutical Holdings Limited
Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.
Employees
1,094
Date Price Change Volume
04/09/26 HK$1.230 -2.38% 1,185,500
03/09/26 HK$1.260 +2.02% 258,000
02/09/26 HK$1.235 -5.73% 1,975,000
01/09/26 HK$1.310 +1.95% 1,465,500
31/08/26 HK$1.285 -4.10% 464,000

Net sales - Rate of surprise